With the analysis among 51 patents, we discovered top 18 key players by total patent application. Regeneron Pharmaceuticals, Inc., REYON PHARMACEUTICAL Co., Ltd., Alnylam Pharmaceuticals, Inc. are dominant in this area. They take 37.25% of the total patent filing.
New York, United States
Patent: 8
Massachusetts, United States
Patent: 5
Gyeonggi-do, South Korea
Patent: 4
Jiangsu Sheng, China
Patent: 4
Chungcheongnam-do, South Korea
Patent: 4
North Carolina, United States
Patent: 1
No data, please try another search term
With the analysis among related 48 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing The University of North Carolina at Chapel Hill, Regeneron Pharmaceuticals, Inc., REYON PHARMACEUTICAL Co., Ltd. take 45.83% of patent filing during this period.
North Carolina, United States
Patent: 8
New York, United States
Patent: 8
Massachusetts, United States
Patent: 5
Jiangsu Sheng, China
Patent: 4
Gyeonggi-do, South Korea
Patent: 4
Chungcheongnam-do, South Korea
Patent: 4
Shanghai Shi, China
Patent: 1
With the analysis among related 48 patents in last 5 years, we discover 13 new entrants. Regeneron Pharmaceuticals, Inc., REYON PHARMACEUTICAL Co., Ltd., Alnylam Pharmaceuticals, Inc. are the most active new entrants in this area.
New York, United States
Patent: 8
Massachusetts, United States
Patent: 5
Jiangsu Sheng, China
Patent: 4
Gyeonggi-do, South Korea
Patent: 4
Chungcheongnam-do, South Korea
Patent: 4
Shanghai Shi, China
Patent: 1
North Carolina, United States
Patent: 1
With the analysis among 31 patents, we discovered top 7 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, Institute For Basic Science, The School of Pharmacy University of London are dominant in this area. They take 70.97% of the total patent filing.
North Carolina, United States
Patent: 11
British Columbia, Canada
Patent: 1
BRISTOL, United Kingdom
Patent: 1
Fujian Sheng, China
Patent: 1
Shanghai Shi, China
Patent: 1